InBios

InBios is a biotechnology company that specializes in designing, developing, and manufacturing immunodiagnostic devices for infectious diseases and biothreats. Its services include assay development and contract manufacturing, including the production of antibodies and antigens for infectious disease research. The company is headquartered in Seattle, Washington.

Founded in 1996, InBios has obtained FDA clearance for ELISA kits for Zika virus, dengue, and West Nile virus, and rapid test kits for Chagas and leishmaniasis. In response to COVID-19, InBios received FDA Emergency Use Authorizations for seven COVID-19 products and also developed additional tests to combat the pandemic.